Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Jessa Hospital | OTHER |
| Algemeen Ziekenhuis Vesalius | OTHER |
| Sint-Franciscus Ziekenhuis | UNKNOWN |
| Regionaal Ziekenhuis Sint-Trudo |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
An adverse event (AE) is defined as unintended injury or complication, which results in disability, death or prolongation of hospital stay, and is caused by healthcare management (including omissions) rather than the patient's disease. Retrospective record reviews in several countries have shown that 2,9% to 16,6% of patients in acute hospitals experience one or more AEs. A patient with an AE may require a higher level of care. Although all AEs are important, preventable AEs that result in an upgraded level of patient care are of particular concern. In this study it's defined as an unplanned admission to intensive care unit (ICU) or a Mobile Emergency Team (MET) intervention. The objectives of this study are to determine the incidence of (preventable) adverse events requiring ICU admission or MET intervention and to assess the level of harm of each AE.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of adverse events requiring a higher level of care | An adverse event is an unintended injury or complication, which results in disability at discharge, death or prolongation of hospital stay, and is caused by healthcare management (including omissions) rather than the patient's disease. (Wilson, 1995) | 6 months |
| The number of participants with preventable adverse events | Assess the preventability of these adverse events using six point scale with a range of not preventable until totally preventable | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Type adverse events | Divide the adverse events into categories, like diagnosis, therapy, medication, surgery, non-surgery, etc. | 6 months |
| Clinical impact of adverse events in terms of outcome |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
primary care clinic
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kristel Marquet, drs | Hasselt University | Principal Investigator |
| Arthur Vleugels, prof. dr. | KU Leuven | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hasselt University | Hasselt | Limburg | 3500 | Belgium |
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D009369 | Neoplasms |
| D009203 | Myocardial Infarction |
| D006333 | Heart Failure |
| D014947 | Wounds and Injuries |
| D003920 | Diabetes Mellitus |
| D008171 | Lung Diseases |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
| UNKNOWN |
| Ziekenhuis Maas en Kempen | OTHER |
| Ziekenhuis Oost-Limburg | OTHER |
Not provided
Not provided
Not provided
Assess the impact of the adverse events in terms of disability, mortality, readmission.
| 6 months |
| Quality of the chart review | The patient chart will be judge on the completeness and adequacy | 6 months |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
| D007238 | Infarction |
| D007511 | Ischemia |
| D009336 | Necrosis |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D012140 | Respiratory Tract Diseases |